Scienture Holdings, Inc.
corporate_fare Company Profile
Scienture Holdings, Inc. (NASDAQ:SCNX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 28 items for SCNX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-19, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for SCNX spans 8-K, 10-Q.
Recent high-impact activity:
- Scienture Q3 Revenue Hits $1.25M, Up 265% Sequentially on REZENOPY Launch
- Scienture Q3 Revenue Jumps 113% to $1.25M as REZENOPY Launch Delivers $925K
- Scienture Regains Nasdaq Bid-Price Compliance; Q3 Revenue Jumps 256% to ~$1.22M
- Scienture's Q3 Revenue Hits $1.22M, Up 256% on REZENOPY Launch
- Arbli™ Lands Formulary Wins at Three Top Pediatric Hospitals
Financial Snapshot
Short Interest & Short Volume
3.14 days to coverFINRA reported short interest of 117,350 shares in SCNX as of the October 30, 2026 settlement, a 10.9% increase from the prior period — about 3.1 days to cover at its recent average daily volume. On November 20, 2026, 37.5% of SCNX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.